Aquestive Therapeutics Director Richard J. Daly Reports Acquisition of $99,330.625 in Common Shares
- Aquestive Therapeutics director Richard J. Daly purchased 1,200 common shares at $3.53 each.
- He bought another 26,825 common shares at $3.545 each.
- The purchases brought his direct beneficial ownership to 28,025 common shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-014004), on November 12, 2026, and is solely responsible for the information contained therein.